The Weekly Roundup: March 21-25

ICYMI, this week we had stories on the latest coverage from the 2022 American Academy of Dermatology Annual meeting, coverage from the 18th Annual Skin of Color Symposium, and more.

POLL: Is Melanoma Over Diagnosed?

The Mainstream Patient: March 21

This week's edition of the Mainstream Patients features stories about scalp acne, how to avoid skin irritation with a fitness tracker, and more.

Opioid prescribing little affected by state laws: study

Implementation challenges and loopholes limit laws’ impact.

Federal Reserve raises interest rates for first time in three years

More hikes expected to help slow rising inflation.

Congress must pass additional funding to fight COVID-19, ACP says

Physicians’ group cites CDC data in letter to lawmakers.

Stop the stigma of weight bias

Physicians have a role in stamping out weight bias.

COVID-19 delays cancer screenings, deaths expected to rise in next 10 years

Cancer programs seek to remove barriers to screenings.

How to Navigate Volatile Markets

In this video the OJM group talks about volatile markets and how to navigate investing in uncertain times.

Study: 75% of Laser Surgery Lawsuits Cite Non-Physician Operators

Laser hair removal was the most litigated.

Machine Learning to Identify Biomarkers in AD

A recent study aimed to identify whether using specific serum biomarkers could predict therapeutic response in patients with atopic dermatitis.

Ongoing Challenges in the Management of Atopic Dermatitis

Experts share insight on the challenges inherent in treating patients with atopic dermatitis despite recent advances in therapy.

Recap of the 3rd Annual San Diego Dermatology Symposium

The 3rd Annual San Diego Dermatology Symposium (SDDS) was held in-person for the first time on March 11 to 13, 2022, at the Hilton San Diego Bayfront, in California.

Key Takeaways on the Management of Atopic Dermatitis

Panelists share parting advice and key takeaways on the optimal management of atopic dermatitis within the treatment landscape.

Patients on Dupilumab Report Long-Term Treatment Satisfaction

Data from the RELIEVE-AD study show long-term control and treatment satisfaction.

Joseph Merola, MD, MMSc, added to Vial Scientific Advisory Board

Vial Dermatology CRO announced that the associate professor of dermatology and rheumatology at Harvard Medical School and the vice chair of clinical trials and innovation at Brigham and Women's Hospital in Boston, Massachusetts, has joined its Scientific Advisory Board.

Tech-enabled Dermascopy’s Impact on Diagnosis, Monitoring, and Patient Management

Leverage Cloud Connectivity to Expand Data Storage, Streamline Workflow

Live from the 18th Annual Skin of Color Scientific Symposium

Today, the 18th Annual Skin of Color Scientific Symposium begins, showcasing new research in the field, key insights, and the evolution in skin of color dermatology.

Treatment Landscape for Atopic Dermatitis

Benjamin Lockshin, MD, FAAD, comments on the significance of recent expansions of therapeutics options for patients with atopic dermatitis and unmet needs in the field.

Phase 2 Trial of Single-Dose Dupilumab in Children with Atopic Dermatitis

Benjamin Lockshin, MD, FAAD, reviews key findings from a phase 2 trial evaluating the safety and efficacy of single-dose dupilumab in children with severe atopic dermatitis.


Future Directions for Dupilumab in Atopic Dermatitis Management

An expert dermatologist evaluates the role of dupilumab in decreasing the clinical burden of severe atopic dermatitis on patients and their caregivers and shares insight on the future outlook of dupilumab in disease management.

Pointers with Dr Portela: How to Obtain Cheaper Skin Prescriptions

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses how treatments are often too expensive for patients, which causes them to be labeled as “non-compliant.” He discusses ways to improve adherence for both patients and doctors

Live from the 2022 American Academy of Dermatology Annual Meeting

The American Academy of Dermatology Annual meeting starts today, offering presentations focusing on the latest treatment updates, new data, plus much more.

Identifying Diagnostic Bias in Skin of Color

Investigator Loren Krueger, MD, urges dermatologists to recognize and correct disparities in clinical decision-making, particularly regarding skin cancer.

Updates in the Management of High-Risk Cutaneous Squamous Cell Carcinoma

Mariam Totonchy, MD, and Chrysalyne D. Schmults, MD, MSCE, discuss best practices when caring for high-risk cSCC patients, including surgical vs nonsurgical options, imaging, and follow-up protocol.

Practical Management of Birthmarks and Hamartomas

In a presentation at the current AAD annual meeting, experts discussed differential diagnoses and clinical presentations in birthmarks and hamartomas.

Alopecia Areata in 2022

In this video interview, we sit down with Natasha Atanaskova Mesinkovska, MD, PhD, FAAD, to discuss her 2022 AAD annual meeting presentation on alopecia areata. We dive into pipeline possibilities, what current treatments are missing, and more.